Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04441112 · ClinicalTrials.gov registry record · Phase 2
Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial
A Phase 2 study of Arthritis Knee and Arthritis of Hip, sponsored by Saint Alphonsus Regional Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04441112: Completed Phase 2 study of Arthritis Knee and Arthritis of Hip, sponsored by Saint Alphonsus Regional Medical Center.
NCT04441112 is a Phase 2 study of Arthritis Knee and Arthritis of Hip that has completed, run by Saint Alphonsus Regional Medical Center. The registered enrollment target is 120 participants, above the 58-participant average among 3 other Arthritis Knee trials with a reported enrollment target (107% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04441112, a Phase 2 study of Arthritis Knee and Arthritis of Hip, has completed, sponsored by Saint Alphonsus Regional Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Clinicians commonly utilize intraarticular injections to treat symptomatic primary arthritis. Steroid injections are common yet have immune-modulating effects and can alter gene expression which may delay definitive arthroplasty and further damage cartilage. Non-steroidal anti-inflammatory (NSAID) injections may offer a safer profile due to their differing mechanism of action; however, there is a relative dearth of information regarding their efficacy. This non-inferiority study compares the effectiveness of triamcinolone versus ketorolac in treating symptoms of moderate to advanced primary osteoarthritis of the hip and knee.
Primary Outcome
Pain Score
Conditions Studied
Interventions
- DRUG Ketorolac Intraarticular Injection
- DRUG Triamcinolone Intraarticular Injection
Study Locations (1)
Idaho
- Saint Alphonsus Regional Medical Center - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-05-20 |
| Est. Completion | 2019-08-20 |
| Phase | Phase 2 |
What the finished NCT04441112 record still lists
NCT04441112 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 58-participant average among 3 other Arthritis Knee trials with a reported enrollment target (107% higher).
The record links to 2 conditions, with Arthritis Knee appearing as the primary indexed condition, and to 2 interventions - of which Ketorolac Intraarticular Injection is the first listed.
NCT04441112 reports a single indexed study location in Idaho.
Frequently Asked Questions
What is clinical trial NCT04441112 about?
NCT04441112 is a clinical study titled "Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial". Clinicians commonly utilize intraarticular injections to treat symptomatic primary arthritis. Steroid injections are common yet have immune-modulating effects and can alter gene expression which may delay definitive arthroplasty and further damage cartilage. Non-steroidal anti-inflammatory (NSAID) i...
What is the current status of trial NCT04441112?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2018-05-20. Estimated completion is 2019-08-20.
What conditions does trial NCT04441112 study?
This clinical trial studies the following conditions: Arthritis Knee, Arthritis of Hip.
What interventions are being tested in trial NCT04441112?
The interventions under investigation include: Ketorolac Intraarticular Injection (DRUG), Triamcinolone Intraarticular Injection (DRUG).
Who is sponsoring clinical trial NCT04441112?
This trial is sponsored by Saint Alphonsus Regional Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04441112 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
RECRUITING · NA
-
Functional Recovery After Total Knee Arthroplasty
RECRUITING
-
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI